MAPT and Alzheimer disease: Characterized by progressive cognitive decline and neuropathological hallmarks including amyloid-β (Aβ) plaques, neurofibrillary tangles (NFTs) of hyperphosphorylated tau, and chronic neuroinflammation, AD remains incurable with existing therapies offering only symptomatic relief [2].